AP1M2 and adrenal cortex carcinoma: As shown in Figure 5(b), the same propensity of PFI survival analysis was revealed as that of the previously described conditions that highly expressed AP1M2 corresponded to poorer prognosis in ACC (P < 0.0001, HR = 1.88, 95% CI = 1.01–3.51), HNSC (P=0.0011, HR = 1, 95% CI = 1–1.01), and MESO (P=0.035, HR = 1.01, 95% CI = 1–1.02).